Bright Minds Biosciences (DRUG) Balance Sheet: Assets & Liabilities

Bright Minds Biosciences (DRUG) Balance Sheet

As of Sep 30, 2025 (end of fiscal 2025), Bright Minds Biosciences reported total assets of CAD 84.42M and total liabilities of CAD 2.38M. Shareholders' equity was CAD 82.04M, up 1381.9% from CAD 5.54M a year earlier. Total debt stood at CAD 125.78K against CAD 82.91M in cash and short-term investments, a net cash position of CAD 82.78M. That puts debt-to-equity at 0.00, compared with 0.02 a year earlier.

Bright Minds Biosciences Balance Sheet Analysis

Values in millions CAD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Bright Minds Biosciences Inc. (DRUG) - Annual data in millions CAD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Sep 2025	Dec 2024	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019
Current Assets
Cash and Cash Equivalents	82.91	5.72	5.72	6.75	11.63	19.76	0.80	0.08
Cash & Short-Term Investments	82.91	5.72	5.72	6.75	11.63	19.76	0.80	0.08
Accounts Receivable	0.41	0.05	0.05	0.04	0.16	0.11	0.00	0.00
Inventory	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.99	0.22	0.22	0.03	0.16	0.17	0.08	0.00
Total Current Assets	84.31	5.99	5.99	6.81	11.95	20.04	0.88	0.08
Non-Current Assets
Property, Plant & Equipment (Net)	0.11	0.12	0.12	0.07	0.14	0.00	0.00	0.00
Long-Term Investments	0.00	0.00	-	0.00	0.00	0.03	0.00	0.08
Goodwill	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	-	0.00	0.00	-0.03	0.00	0.00
Total Non-Current Assets	0.11	0.12	0.12	0.07	0.14	0.00	0.00	0.08
Total Assets	84.42	6.10	6.10	6.88	12.09	20.04	0.88	0.16
Current Liabilities
Accounts Payable	1.71	0.41	0.41	0.18	1.25	0.60	0.14	0.04
Short-Term Debt	0.08	0.08	-	0.07	0.07	0.00	0.00	0.00
Accrued Liabilities	0.54	-	0.04	0.03	0.16	0.04	-	-
Other Current Liabilities	0.54	0.04	-	0.03	0.16	0.04	0.01	0.00
Total Current Liabilities	2.34	0.53	0.53	0.28	1.47	0.64	0.15	0.04
Non-Current Liabilities
Long-Term Debt	0.04	0.04	0.04	0.00	0.07	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.04	0.04	0.04	0.00	0.07	0.00	0.00	0.00
Total Liabilities	2.38	0.57	0.57	0.28	1.54	0.64	0.15	0.04
Stockholders' Equity
Common Stock	123.25	35.42	35.42	33.91	32.24	27.08	0.98	0.21
Retained Earnings	-46.58	-34.35	-34.35	-31.55	-24.17	-9.21	-0.56	-0.08
Accumulated Other Comprehensive Income	5.37	4.01	4.46	4.23	2.48	1.57	0.16	-0.08
Additional Paid-in Capital	0.00	0.46	-	0.00	0.00	-0.03	-	0.08
Shares Outstanding	7.64	-	4.52	3.77	3.52	-	-	-
Total Stockholders' Equity	82.04	5.54	5.54	6.60	10.54	19.40	0.73	0.13
Total Liabilities & Equity	84.42	6.10	6.10	6.88	12.09	20.04	0.88	0.16

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bright Minds Biosciences Balance Sheet

How much debt does Bright Minds Biosciences have?

Bright Minds Biosciences had total debt of CAD 125.78K as of Sep 30, 2025, against CAD 82.91M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was CAD 118.96K a year earlier.

What are Bright Minds Biosciences's total assets?

Bright Minds Biosciences reported total assets of CAD 84.42M as of Sep 30, 2025, up 1282.9% from CAD 6.10M a year earlier. Total liabilities were CAD 2.38M.

What is Bright Minds Biosciences's shareholders' equity?

Bright Minds Biosciences's shareholders' equity was CAD 82.04M as of Sep 30, 2025, or about CAD 10.74 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition